It's early days for xenotransplantation, but eGenesis, Eledon, United Therapeutics and more are working to develop solutions ...

Approval of Vykat XR marks the first treatment indicated for hyperphagia in patients with Prader-Willi syndrome.

Dr. Shivaani Kummar is stepping into the role of OHSU Knight Cancer Institute chief executive on an interim basis, OHSU ...

Augustine Therapeutics raises oversubscribed EUR 78 million / USD 85 million Series A financing round Novo Holdings and Jeito Capital co-led the deal, supported by Asabys Partners and existing investo ...

Corsair Pharma Announces Successful Completion of Preclinical Program for Its Treprostinil Prodrug Transdermal System ...

and I believe this transaction will maximize value for our stockholders and provide accelerated access to Unloxcyt in the United States, Europe, and other markets worldwide." 1. Sun Pharma to Acquire ...

Multinational pharmaceutical firms, particularly U.S. giants, are increasingly recognizing China's burgeoning innovative drug sector as a strategic goldmine to bolster their global competitiveness.

President & CEO of Arcturus Therapeutics. "Arcturus continues to make excellent progress with our STARR® sa-mRNA vaccines pipeline and platform. We are very pleased to have recently received ...

A kickoff meeting was recently held in March in the United States ... dermatitis market," said Janice Marie McCourt, CEO of Hudson Therapeutics. "We have strong interest from numerous specialty ...

Heron Therapeutics' market cap has risen to ~$360 ... In response to a question about Heron's expectations about VAN's impact CEO Collard advised: ...what we're seeing is the reception so far ...